Oku Tsuneyuki, Tanabe Kenichi, Ogawa Shigeharu, Sadamori Naoki, Nakamura Sadako
Graduate School of Human Health Science, University of Nagasaki, Siebold, Nagayo, Japan;
Clin Exp Gastroenterol. 2011;4:155-61. doi: 10.2147/CEG.S19961. Epub 2011 Jun 27.
The purpose of this study was to clarify whether it is possible to extrapolate results from studies of the hydrolyzing activity of disaccharidases from rats to humans.
We measured disaccharidase activity in humans and rats using identical preparation and assay methods, and investigated the similarity in hydrolyzing activity. Small intestinal samples without malignancy were donated by five patients who had undergone bladder tumor surgery, and homogenates were prepared to measure disaccharidase activity. Adult rat homogenates were prepared using small intestine.
Maltase activity was the highest among the five disaccharidases, followed by sucrase and then palatinase in humans and rats. Trehalase activity was slightly lower than that of palatinase in humans and was similar to that of sucrase in rats. Lactase activity was the lowest in humans, but was similar to that of palatinase in rats. Thus, the hydrolyzing activity of five disaccharidases was generally similar in humans and rats. The relative activity of sucrose and palatinase versus maltase was generally similar between humans and rats. The ratio of rat to human hydrolyzing activity of maltase, sucrase, and palatinase was 1.9-3.1, but this was not a significant difference. Leaf extract from Morus alba strongly inhibited the activity of maltase, sucrase, and palatinase, but not trehalase and lactase, and the degree of inhibition was similar in humans and rats. L-arabinose mildly inhibited sucrase activity, but hardly inhibited the activity of maltase, palatinase, trehalase and lactase in humans and rats. The digestibility of 1-kestose, galactosylsucrose, and panose by small intestinal enzymes was very similar between humans and rats.
These results demonstrate that the digestibility of newly developed saccharide materials evaluated by rat small intestinal enzymes can substitute for evaluation using human enzymes.
本研究的目的是阐明是否有可能将大鼠双糖酶水解活性研究的结果外推至人类。
我们使用相同的制备和测定方法测量了人类和大鼠的双糖酶活性,并研究了水解活性的相似性。五名接受膀胱肿瘤手术的患者捐赠了无恶性病变的小肠样本,并制备匀浆以测量双糖酶活性。使用大鼠小肠制备成年大鼠匀浆。
在人类和大鼠中,麦芽糖酶活性在五种双糖酶中最高,其次是蔗糖酶,然后是帕拉金酶。海藻糖酶活性在人类中略低于帕拉金酶,在大鼠中与蔗糖酶活性相似。乳糖酶活性在人类中最低,但在大鼠中与帕拉金酶活性相似。因此,五种双糖酶的水解活性在人类和大鼠中总体相似。蔗糖酶和帕拉金酶相对于麦芽糖酶的相对活性在人类和大鼠之间总体相似。麦芽糖酶、蔗糖酶和帕拉金酶的大鼠与人类水解活性之比为1.9 - 3.1,但这不是显著差异。桑叶提取物强烈抑制麦芽糖酶、蔗糖酶和帕拉金酶的活性,但不抑制海藻糖酶和乳糖酶的活性,并且抑制程度在人类和大鼠中相似。L -阿拉伯糖轻度抑制蔗糖酶活性,但几乎不抑制人类和大鼠中麦芽糖酶、帕拉金酶、海藻糖酶和乳糖酶的活性。1 -蔗果三糖、半乳糖基蔗糖和潘糖被小肠酶的消化率在人类和大鼠之间非常相似。
这些结果表明,用大鼠小肠酶评估新开发糖类材料的消化率可替代用人酶进行的评估。